Fulcrum Therapeutics Earnings
NASDAQ: FULCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.77+0.02 (+0.53%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.10
Fulcrum Therapeutics earnings summary
Fulcrum Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.10.
Summary generated from market data by MetaCap's automated system. Methodology